DRW Securities’s Pfizer PFE Stock Holding History

DRW Securities’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-157,500	Closed	-$4.02M	–	1579
2025 Q3	$4.02M	Buy	+157,500	New	+$3.89M	0.07%	150
2022 Q2	–	Sell	-31,500	Closed	-$1.63M	–	329
2022 Q1	$1.63M	Buy	+31,500	New	+$1.63M	0.04%	105

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DRW Securities's PFE Position: Q2 2026 in Review

DRW Securities sold out of Pfizer (PFE) in Q2 2026, closing a stake of 22,683 shares — an estimated $637K sold.

DRW Securities first reported a position in PFE in Q2 2013 and held it in 17 quarters. The position peaked at $3.71M in Q4 2015. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

DRW Securities reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 22,683 Pfizer shares in Q2 2026, an estimated $637K.
DRW Securities first reported a position in Pfizer in Q2 2013 and held it in 17 quarters.
DRW Securities's Pfizer position peaked at $3.71M in Q4 2015.
2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.